This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Weiss & Lurie, a national class action and shareholder rights law firm with offices in New York City and Los Angeles, is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Caliper Life Sciences Inc. (NASDAQ:CALP) arising from its proposed acquisition by PerkinElmer Inc. (NYSE:PKI) for $10.50 per share in cash. The transaction is expected to close in the fourth quarter of 2011, subject to customary closing conditions, including regulatory and Caliper shareholder approvals. Caliper CEO Kevin Hrusovsky is expected to join the Perkin Elmer senior leadership team following the close of the transaction.
Weiss & Lurie is investigating whether Caliper’s Board acted in the best interests of its shareholders in approving the transaction and whether the Board undertook a fair sales process. Notably, the Company exceeded all of its key financial objectives for 2010 and its stock has experienced steady gains in the past 52 weeks, rising from a low of $3.31 per share on September 10, 2010 to a recent high of $8.68 on August 3, 2011.
If you own Caliper shares and would like more information about your rights as a shareholder or additional information concerning our investigation, please contact Julia J. Sun either by email at firstname.lastname@example.org or by telephone at (888) 593-4771.
Weiss & Lurie has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded institutions and individuals and obtained important corporate governance in these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or issuing materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at email@example.com or fill out the form on our website, http://www.weisslurie.com/contact/report_fraud/.